Services
Trinity’s research studies are designed and conducted to support ongoing and dynamic solutions at every stage of the marketing lifecycle. Our capabilities range from qualitative in-depth interviews to multivariate quantitative studies with physicians, patients, payers, and other critical stakeholders in the healthcare space.
Trinity Patient Centricity focuses on deeply understanding patient needs and experiences to support life science organizations in product development, launch and beyond.
Sentiment is a healthcare research panel organized and led by Trinity Life Sciences. Sentiment’s network is currently comprised of health care practitioners, patients, payers, clinical administrators and key opinion leaders.
Offerings
Latest Insights Intelligence
Webinars
Business Development: Getting Pricing & Access Inputs Right
Now Available On Demand: Trinity invites life sciences executives to join us for a dynamic discussion on the most common high-impact challenges inherent in Business Development: Chad Faulkner, Partner in Trinity’s Strategic Advisory practice, will host this session and moderate a panel with special guests Monica Martin De Bustamante—Senior Partner & Head of Evidence, Value, […]
Watch Now
Webinars
Make Rapid Decisions with Confidence: Trinity’s Approach to Business Development Assessments
Life science companies are often faced with situations that require quick decisions—from triage and/or pre-diligence phases through full due diligence. Trinity’s expert team routinely provides time-sensitive business development support, delivering robust insights and evidence-based answers in days. Come join us for a dynamic discussion on evaluating Business Development opportunities in life sciences. Key Webinar Topics […]
Watch Now
White Papers
Empowering the Next-Generation Launch Model
The pharma industry has seen dramatic shifts in scientific innovation over the last decade with a trend toward orphan markets, personalized medicine, higher priced products and new modalities including cell and gene therapies, oligonucleotides and others. COVID served to further accelerate scientific innovation, driving a near record-breaking number of FDA approvals, astronomical venture capital funding […]
Read More
If you have any questions, we’re here to answer them.
We look forward to helping identify solutions for you.